GS
AMAG

GAM Systematic’s AMAG Pharmaceuticals AMAG Stock Holding History

GAM Systematic’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,191
Closed -$72K – 658
2017
Q1 		$72K Sell
3,191
-18,960
-86% -$454K 0.01% 555
2016
Q4 		$771K Buy
+22,151
New +$662K 0.18% 236
2015
Q4 		– Sell
-10,661
Closed -$424K – 707
2015
Q3 		$424K Buy
+10,661
New +$662K 0.1% 378

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GAM Systematic's AMAG Position: Q2 2017 in Review

GAM Systematic sold out of AMAG Pharmaceuticals (AMAG) in Q2 2017, closing a stake of 3,191 shares — an estimated $72K sold.

GAM Systematic first reported a position in AMAG in Q3 2015 and held it in 3 quarters. The position peaked at $771K in Q4 2016. 174 funds tracked by Wall St. Rank hold AMAG as of Q2 2017.

  • GAM Systematic reported no remaining AMAG Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • GAM Systematic sold 3,191 AMAG Pharmaceuticals shares in Q2 2017, an estimated $72K.
  • GAM Systematic first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 3 quarters.
  • GAM Systematic's AMAG Pharmaceuticals position peaked at $771K in Q4 2016.
  • 174 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2017.

Based on GAM Systematic's 13F filing for Q2 2017, filed 14 Aug 2017.